Company Filing History:
5 out of 1,209 
1 out of 2 
1 out of 17 Years Active: 2013-2023
Title: The Innovative Contributions of Dharminder Chauhan
Introduction
Dharminder Chauhan is a notable inventor based in Natick, MA, who has made significant contributions to the field of biomedical research. With a total of six patents to his name, Chauhan's work focuses on developing small molecules that induce selective protein degradation, which has important implications for treating various diseases.
Latest Patents
Chauhan's latest patents include groundbreaking compounds designed to bind target proteins and induce their degradation. One of his notable inventions involves bifunctional compounds that bind to bromodomain-containing proteins or histone methyltransferases, promoting their degradation by recruiting them to the ubiquitin receptor RPN13 for proteasomal degradation. This innovation has potential applications in treating proliferative diseases, cancers, and autoimmune diseases. Another significant patent involves small molecules that block the function of the proteasome-associated ubiquitin receptor RPN13, which can inhibit proteasome function and aid in the treatment of similar diseases.
Career Highlights
Throughout his career, Dharminder Chauhan has worked with prestigious institutions, including the Dana-Farber Cancer Institute. His research has contributed to advancements in understanding and treating complex diseases, showcasing his commitment to innovation in the biomedical field.
Collaborations
Chauhan has collaborated with esteemed colleagues such as Kenneth Carl Anderson and Michael A. Palladino, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Dharminder Chauhan's innovative work in developing small molecules for protein degradation represents a significant advancement in biomedical research. His contributions have the potential to lead to new treatments for various diseases, underscoring the importance of his inventions in the scientific community.